Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Myron Levin to Immune Sera

This is a "connection" page, showing publications Myron Levin has written about Immune Sera.

 
Connection Strength
 
 
 
0.830
 
  1. Levin MJ, Duchon JM, Swamy GK, Gershon AA. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program. PLoS One. 2019; 14(7):e0217749.
    View in: PubMed
    Score: 0.644
  2. Duchon JM, Levin MJ, Gershon AA. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program. J Pediatric Infect Dis Soc. 2020 Sep 17; 9(4):449-453.
    View in: PubMed
    Score: 0.175
  3. Zaia JA, Levin MJ, Wright GG, Grady GF. A practical method for preparation of varicella-zoster immune globulin. J Infect Dis. 1978 May; 137(5):601-4.
    View in: PubMed
    Score: 0.009
  4. Levine AS, Oxman MN, Henry PH, Levin MJ, Diamandopoulos GT, Enders JF. Virus-specific deoxyribonucleic acid in simian virus 40-exposed hamster cells: correlation with S and T antigens. J Virol. 1970 Aug; 6(2):199-207.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)